Elacestrant Improves Progression-Free Survival After Endocrine Therapy for Estrogen Receptor-Positive Metastatic Breast Cancer

被引：4
|
作者：
Jacobson, Anne
机构：
来源：
ONCOLOGIST | 2022年 / 27卷
关键词：
D O I：
10.1093/oncolo/oyac015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：S7 / S8
页数：2
相关论文
共 50 条
  • [21] Advances in Endocrine-Based Therapies for Estrogen Receptor-Positive Metastatic Breast Cancer
    Vassilis Aggelis
    Stephen R. D. Johnston
    Drugs, 2019, 79 : 1849 - 1866
  • [22] Endocrine therapy combined with targeted therapy in hormone receptor-positive metastatic breast cancer
    Bian Li
    Xu Feng-Rui
    Jiang Ze-Fei
    中华医学杂志英文版, 2020, 133 (19) : 2338 - 2345
  • [23] Endocrine therapy combined with targeted therapy in hormone receptor-positive metastatic breast cancer
    Bian, Li
    Xu, Feng-Rui
    Jiang, Ze-Fei
    CHINESE MEDICAL JOURNAL, 2020, 133 (19) : 2338 - 2345
  • [24] Improved progression-free survival in metastatic breast cancer
    Burki, Talha Khan
    LANCET ONCOLOGY, 2018, 19 (02): : E79 - E79
  • [25] Prolonged progression-free survival in metastatic breast cancer
    Mayor, Susan
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2008, 69 (07) : 378 - 378
  • [26] Panitumumab improves progression-free survival in metastatic colorectal cancer
    不详
    ONCOLOGY-NEW YORK, 2005, 19 (14): : 1800 - 1801
  • [27] Longer progression-free survival with targeted therapy for patients with metastatic breast cancer
    Nierengarten, Mary Beth
    CANCER, 2025, 131 (07)
  • [28] A practical guide to endocrine therapy in the management of estrogen receptor-positive male breast cancer
    Yadav, Siddhartha
    Giridhar, Karthik, V
    Leone, Jose Pablo
    Leon-Ferre, Roberto A.
    Ruddy, Kathryn J.
    BREAST CANCER MANAGEMENT, 2021, 10 (03)
  • [29] Predictors of response to exemestane as primary endocrine therapy in estrogen receptor-positive breast cancer
    Yamashita, Hiroko
    Takahashi, Satoru
    Ito, Yukashi
    Yamashita, Toshinari
    Ando, Yoshiaki
    Toyama, Tatsuya
    Sugiura, Hiroshi
    Yoshimoto, Nobuyasu
    Kobayashi, Shunzo
    Fujii, Yoshitaka
    Iwase, Hirotaka
    CANCER SCIENCE, 2009, 100 (11) : 2028 - 2033
  • [30] Predictors of Response to Exemestane as Primary Endocrine Therapy in Estrogen Receptor-Positive Breast Cancer
    Yoshimoto, N.
    Takahashi, S.
    Ito, Y.
    Yamashita, T.
    Ando, Y.
    Toyama, T.
    Sugiura, H.
    Kobayashi, S.
    Fujii, Y.
    Iwase, H.
    Yamashita, H.
    CANCER RESEARCH, 2009, 69 (24) : 605S - 605S
12345